0001127602-19-003737.txt : 20190204 0001127602-19-003737.hdr.sgml : 20190204 20190204161308 ACCESSION NUMBER: 0001127602-19-003737 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190131 FILED AS OF DATE: 20190204 DATE AS OF CHANGE: 20190204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Babu Yarlagadda S CENTRAL INDEX KEY: 0001452635 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 19563814 MAIL ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-01-31 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001452635 Babu Yarlagadda S 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 Senior VP - Drug Discovery Common Stock 2019-01-31 4 M 0 19686 1.20 A 127786 D Common Stock 2019-01-31 4 F 0 7702 8.68 D 120084 D Common Stock 2019-01-31 4 M 0 12188 1.20 A 132272 D Common Stock 2019-01-31 4 F 0 1685 8.68 D 130587 D Non-Qualified Stock Option 1.20 2019-01-31 4 M 0 19686 0 D 2010-03-02 2019-03-02 Common Stock 19686 0 D Emp. Stock Option (Right to Buy) 1.20 2019-01-31 4 M 0 12188 0 D 2010-03-02 2019-03-02 Common Stock 12188 0 D Shares of Common Stock delivered to the Company to satisfy payment of exercise price and tax withholding in connection with stock option exercise. Shares of Common Stock delivered to the Company to satisfy payment of exercise price in connection with stock option exercise. /s/ Alane P. Barnes, by power of attorney 2019-02-04